According to ReWalk Robotics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.18212. At the end of 2022 the company had a P/E ratio of -2.38.
Year | P/E ratio | Change |
---|---|---|
2022 | -2.38 | -47.87% |
2021 | -4.56 | 214.06% |
2020 | -1.45 | 102.81% |
2019 | -0.7152 | 152.72% |
2018 | -0.2830 | -67.07% |
2017 | -0.8594 | -23.88% |
2016 | -1.13 | -83.54% |
2015 | -6.86 | 68.86% |
2014 | -4.06 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Abiomed ABMD | 64.8 | -2,136.36% | ๐บ๐ธ USA |
Hologic HOLX | 39.0 | -1,325.60% | ๐บ๐ธ USA |
ResMed RMD | 35.4 | -1,211.83% | ๐บ๐ธ USA |
Nevro
NVRO | -3.95 | 24.27% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.